CC
QTTB icon

Casdin Capital’s Q32 Bio QTTB Stock Holding History

Casdin Capital’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-45,556
Closed -$14.8M – 34
2019
Q3 		$14.8M Buy
45,556
+4,167
+10% +$1.42M 1.54% 20
2019
Q2 		$14.6M Buy
41,389
+21,945
+113% +$8.62M 1.36% 23
2019
Q1 		$9.71M Hold
19,444
– – 1.07% 23
2018
Q4 		$7.83M Hold
19,444
– – 1.34% 25
2018
Q3 		$8M Buy
19,444
+13,055
+204% +$4.43M 0.97% 27
2018
Q2 		$2.35M Buy
6,389
+3,056
+92% +$1.09M 0.33% 33
2018
Q1 		$1.12M Buy
+3,333
New +$1.12M 0.2% 31

Other funds holding QTTB

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Casdin Capital's QTTB Position: Q4 2019 in Review

Casdin Capital sold out of Q32 Bio (QTTB) in Q4 2019, closing a stake of 45,556 shares — an estimated $14.8M sold.

Casdin Capital first reported a position in QTTB in Q1 2018 and held it in 7 quarters. The position peaked at $14.8M in Q3 2019. 86 funds tracked by Wall St. Rank hold QTTB as of Q4 2019.

  • Casdin Capital reported no remaining Q32 Bio position as of Q4 2019 after selling out during the quarter.
  • Casdin Capital sold 45,556 Q32 Bio shares in Q4 2019, an estimated $14.8M.
  • Casdin Capital first reported a position in Q32 Bio in Q1 2018 and held it in 7 quarters.
  • Casdin Capital's Q32 Bio position peaked at $14.8M in Q3 2019.
  • 86 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2019.

Based on Casdin Capital's 13F filing for Q4 2019, filed 14 Feb 2020.